Funding - February 10, 2015
AstraZeneca Funds Cardiac Care
The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular HealthSM program is awarding a grant of $152,763 to Manna Ministries Inc. to support its Heart 2 Heart Initiative which works to improve cardiovascular health in a community. This is the second consecutive year in which Manna Ministries has received a grant from the AstraZeneca HealthCare Foundation, totaling […]
Funding - December 10, 2014
Sweden to Invest More in Climate Change, Life Sciences
In the draft Swedish federal budget for 2015, the government proposes that the mandate of the Fourier transform be changed. Today the fund, which manages 3 billion, focuses on the automotive industry. But according to the proposal, the mission instead becomes to directly or indirectly invest in small to medium sized businesses in the early stages […]
Funding - December 3, 2014
Oslo Cancer Cluster Names Research Grant Winners
Oslo Cancer Cluster recently named three winners in a competition seeking collaborative projects involving immuno-oncology. The three, BerGen Bio, Targovax and Ultimovacs each will receive MNOK 0,4 from Innovation Norway. BerGenBio will use the award to prove that Axl kinase inhibition may provoke an anti-tumor immune response, working with partners from the University of Bergen, Oslo, […]
Funding - November 25, 2014
Beactica Receives Grant
Beactica, the Swedish fragment-based drug discovery company, announced that it has been awarded a SEK 3.0 million grant from the Swedish Governmental Agency for Innovation Systems (VINNOVA). The grant will be used to support the development of a new epigenetic drug for treatment of cancer. The goal of Beactica’s project is to develop novel compounds for […]
Funding - September 24, 2014
BerGenBio granted drug discovery award
Oncology biopharmaceutical company BerGenBio has been granted a GBP 1.6 million seeding drug discovery award from the UK’s Wellcome Trust. The money will go to develop novel small molecule inhibitors against BGB002, its proprietary, novel cancer target. BGB002 controls tumour cell malignant features. This gene is up-regulated in several cancer types including the difficult to treat malignancies such as triple-negative-breast cancer. BerGenBio holds […]
Funding - September 3, 2014
Funding to heart researcher
Prince Daniel’s funding to young promising scientists will this year be allocated to Lars Maegdefessel for his research on preventing hardening of the arteries. Maegdefessel is doctor of medicine at Karolinska Insitutet in Stockholm and does his research on the mikroRNA molecule and its importance in developing hardening of the arteries. The goal of the […]
